# NUCALA
> **BLA761122** · Biologics License Application · Sponsor: GLAXOSMITHKLINE · Approved 2019-06-06
## Drug
- **FDA Application Number:** BLA761122
- **Application type:** Biologics License Application
- **Brand name:** NUCALA
- **Generic name:** MEPOLIZUMAB
- **Active ingredients:** MEPOLIZUMAB
- **Dosage form:** INJECTABLE
- **Route:** SUBCUTANEOUS
- **Marketing status:** Prescription
- **Sponsor:** GLAXOSMITHKLINE
- **Manufacturer:** GlaxoSmithKline LLC
- **First approval:** 2019-06-06
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761122)
---
*AI Analytics · CC0 1.0*